Guest Post
Gloom & Doom Abounds, But Facts Don’t Support It
Value Briefs
Price vs. Value
Dividend Aristocrats In Focus Part 6: Abbott Laboratories
Amdocs, Ltd. (DOX): Re-DOX Of Dot.com Stock Collapse?
Value Briefs
We See Dead Stocks
January 2019 Data Update 4: The Many Faces Of Risk!
Put Into Perspective: Hedge Funds’ Missed Opportunity
Dividend Aristocrats In Focus Part 5: ExxonMobil
U.S. Equity Market January 2019 Chart Book
2019 Global Private Equity Survey
Dividend Aristocrats In Focus Part 4: ADP
Dividend Aristocrats In Focus Part 3: Federal Realty Investment Trust
In Asia, China Is Least Correlated To The US Market
Dividend Aristocrats In Focus Part 2: Consolidated Edison
Citron Claims “Smoking Gun” On Ligand Pharmaceuticals
Dividend Aristocrats In Focus Part 1: AT&T
Hoax Compels BlackRock To Bigly Wig Out
Fed Will ‘Wait & Watch’ Before Raising Interest Rates
